The KEGG pathway analysis is presented in Figure 5b, highlighting that Dio primarily impacts pathways related to (1) EGFR tyrosine kinase inhibitor (TKI) resistance, (2) pathways in cancer, (3) PI3K-Akt signaling pathway, and (4) proteoglycans in cancer. This evidence concerns the gene AKT1 and cancer.